Coronavirus

AAFP Board Chair Sterling Ransone, Jr, MD, offers an Academy refresher on the annual push-back from patients that is so familiar to family medicine clinicians.

About half of American adults plan not to get a flu shot this year; everyone is tired of COVID talk and prevention; but flu is brewing in the southern hemisphere, Ransone says.

Your daily dose of clinical news from Patient Care Online.

Ransone hasn't had a case of influenza in his practice in 2 years, but with mitigation measures all but over and COVID-19 in the wings, this year could be different.

Smoking, age, diabetes, race/ethnicity, and BMI may all pose a greater risk for mortality in severe COVID-19 infection than preexisting CVD, study suggests.

The FDA amended EUAs for omicron-adapted vaccines from both Pfizer and Moderna, authorizing the shots for children and adolescents.

A large cohort study confirms the observed efficacy of initial and follow-up COVID-19 vaccination and prior infection against infection, hospitalization, and death.

Elizabeth Sapey, PhD, discusses how the updated treatment recommendations from the World Health Organization may impact future use of remdesivir.

More than 4 in 10 US adults have either misrepresented their COVID-19 status or failed to adhere to public health measures. A new survey found out why.

Elizabeth Sapey, PhD, discusses findings from the SOLIDARITY study and similar research on the efficacy of remdesivir for treatment of severe disease.

Influenza rates were higher in Australia during the April-October season this year than they have been in 5 years. Should we be preparing now?

Elizabeth Sapey, PhD, discusses the updated recommendations and the research that prompted the decision.

Refractory adult misbeliefs about vaccine safety have increased reluctance to vaccinate US children aged 5-11 years, according to an Annenberg Public Policy center survey.

Telehealth continues to support continuity of care and to increase access to and willingness to use the health care system, according to survey authors.

WHO: Evidence is lacking for clinical effectiveness of Xevudy and Regen-Cov against the COVID-19 variants that are currently circulating.

Data from the CDC on US vaccination and booster shot rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

Data from the CDC on US vaccination and booster shot rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

Data from the CDC on US vaccination and booster shot rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

Data from the CDC on US vaccination and booster shot rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

The performance of 3 commercially available COVID-19 home-testing kits worsened during the emergence of the omicron variant, according to a new cross-sectional study.

Data from the CDC on US vaccination and booster shot rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

Long COVID is now recognized as real, in the medical community and in Washington, DC, but 2 years ago it was a different story, says AAPM&R's Steven Flanagan, MD.

Data from the CDC on US vaccination and booster shot rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

NYU Langone Rusk Rehabilitation medical director Steven Flanagan, MD, discusses the "second crisis" of the pandemic and the impact on primary care.

Long COVID symptoms are reported by persons who have had only mild disease, who have been vaccinated and boosted, and even those who had asymptomatic infection.